Annual report [Section 13 and 15(d), not S-K Item 405]

CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

v3.26.1
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
Revenues $ 19,529 $ 14,288
Cost of revenues 12,114 8,823
Gross profit 7,415 5,465
Operating expenses:    
Research and development 2,271 1,814
Selling, general and administrative 7,605 7,361
Total operating expenses 9,876 9,175
Loss from operations (2,461) (3,710)
Other (expense) income (958) 803
Loss from operations before income taxes (3,419) (2,907)
Income tax benefit (expense) 244 (550)
Net loss $ (3,175) $ (3,457)
Net loss per share: basic $ (1.89) $ (2.79)
Net loss per share: diluted $ (1.89) $ (2.79)
Weighted-average shares outstanding: basic 1,684 1,241
Weighted-average shares outstanding: diluted 1,684 1,241
Other comprehensive loss:    
Net loss $ (3,175) $ (3,457)
Foreign currency translation adjustments 1,133 (1,653)
Comprehensive loss $ (2,042) $ (5,110)